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Abstract  
Background;  
Historically dacryocystorhinostomy (DCR) has been performed externally with very good 
outcomes. Current literature shows comparable success rates between endonasal and 
external approaches. A common reason for the failure of a DCR is the re-closure of the 
nasolacrimal stoma by granulation tissue and synechiae. 
 
 
This is the peer reviewed version of the following article: 'Mucosal and lacrimal flaps for endonasal dacryocystorhinostomy 
(DCR) a systematic review', which has been published in final form at http://dx.doi.org/10.1111/coa.12754. This article may 
be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.
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Objective of review;  
A systematic review and critical evaluation of the evidence relating to the preservation of 
nasal mucosal flaps in DCR surgery. 
 
Type of review and evaluation method;  
A systematic review using the consort guidance for review of randomised control trials. 
 
Search strategy;  
A search of the following evidence-based medicine databases was performed: Cochrane 
database of systematic reviews (DSR), Database of abstracts of reviews of effectiveness 
(DARE), Cochrane central register of controlled trials (CCTR), Ovid, Medline, EMBASE, 
PubMed. The search was limited to English language articles and the following key words 
were used: Endonasal, Endoscopic, Dacryocystorhinostomy, DCR, Mucosal Flaps, between 
years 1970 and 2015.  
 
Results; 
The best available evidence was level 1B, comprising 2 randomised control trials and 3 
comparative studies included in the review. The main outcome measures used were 
lacrimal irrigation and absence of epiphora. Two of the studies demonstrated a statistically 
significant benefit of mucosal sparing either with nasal mucosal flaps or lacrimal flaps. More 
debridement was needed and granulation tissue was also seen in the groups without 
mucosal preservation. There was no difference in surgical complications between a mucosal 
and non-mucosal sparing technique.  
 
Conclusions; 
The overall quality of current evidence is poor, there does however appear to be a trend 
towards improved outcomes and reduced granulation in groups where nasal mucosal and 
lacrimal flaps were preserved, but this is not clear-cut. There was no evidence of increased 
complication rates with mucosal sparing techniques. We recommend that until further good 
quality research is available we should be performing a mucosal sparing technique when 
performing DCR routinely. 
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Key Points 
• Little evidence with only two level 1B RCTs and three comparative studies available 
to review 
• There is some evidence that mucosal flaps improve outcome measures, such as 
lacrimal irrigation and absence of epiphora 
• Evidence suggests that fewer granulations and nasal debridement required in 
mucosal sparing techniques 
• No increase in surgical complications with mucosal sparing techniques 
• We recommend future studies include the use of a validated quality-of-life (QoL) 
measure for outcome assessment. 
 
Introduction 
Historically dacryocystorhinostomy (DCR) has been performed externally with very good 
outcomes 1. The development of endonasal instrumentation and modern visual technology 
has led to the endoscopic approach now being the preferred surgical technique in many 
centres. Current literature shows comparable success rates between endonasal and 
external approaches however the endonasal technique avoids an external scar 2. 
 
Endonasal DCR was first described by Caldwell in 1893, the major limitation being the 
equipment available at that time 3. The first clinical study of endonasal DCR was by 
McDonogh et al in 1989 4. The technique describes the removal of the nasal mucosal flap 
and suturing the lacrimal flap to the inferior turbinate.  
 
Conventional endonasal DCR had created a fistula between the lacrimal sac and the nasal 
cavity without the preservation of the nasal mucosa.  A common reason for the failure of a 
DCR is the re-closure of the nasolacrimal stoma by granulation tissue and synechiae 5. Many 
approaches have been used to try and improve the success rates of endonasal DCR, from 
silicone stents to mitomycin C application. Another commonly held belief is that the 
preservation of nasal mucosal flaps can help reduce the rate of granulation and synechiae 
formation. There has been a progressive evolution of DCR surgery with several authors 
describing different techniques of nasal mucosal preservation and flap creation. These 
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include the U-shaped 6, L-shaped mucosal flap 7, free nasal mucosal flap 8, and the 
preservation of the whole nasal mucosal flap 9. We present a review of the current 
literature on this subject. 
 
Objective of the review: To systematically review and critically evaluate the evidence 
relating to the preservation of nasal mucosal flaps in DCR surgery.  
 
Methods: A systematic review of the literature was performed to identify papers on the 
subject of mucosal flap use in DCR surgery. A search of the following evidence-based 
medicine databases was performed: the Cochrane Database of Systematic Reviews (DSR), 
Database of Abstracts of Reviews of Effects (DARE), Cochrane Central Register of Controlled 
Trials (CCTR), Ovid, Medline, EMBASE and PubMed. The search was limited to English 
language articles. The search terms used were: Endonasal, Endoscopic, 
Dacryocystorhinostomy, DCR, Mucosal Flaps. Articles between years 1970 and 2015 were 
used. Titles and abstracts were screened and the all the RCTs that compared mucosal flaps 
to no mucosal flaps or compared differing mucosal flaps were included (Figure 1).  
 
Two independent reviewers assessed the relevant articles using the CONSORT Statement 
guidance on reporting of randomised trials 10. 
 
Results: The best evidence available was level 1B, there were 2 randomised control trials 
(RCTs). The 2 RCTs form the main basis of the review, there are also 3, level 2 comparative 
studies included that we felt were clinically relevant. Of the 3 comparative studies, 1 
compares nasal mucosal flaps and 2 compare lacrimal flaps. The review is predominantly 
broken down in to mucosal flaps and lacrimal flaps.  
 
Cumulatively there are 188 patients in the RCT groups with 373 in the comparative studies: 
n = 561 patients.  
 
The five studies included for discussion with their surgical intervention, outcome measures, 
success rates and complications are listed in Tables 1 and 2.  
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Table 1. RCTs and comparative studies showing surgical intervention, outcome measures, 
success rates and complications for nasal mucosal flaps versus no flaps. 
 
Table 2. Comparative studies showing surgical intervention, outcome measures, success 
rates and complications for differing lacrimal sac flaps. 
 
Outcome measures; 
Lacrimal irrigation and absence of epiphora: In the two RCTs the main outcome measures 
were lacrimal irrigation and absence of epiphora 11,12. The three comparative studies all 
utilised lacrimal irrigation or a fluorescein test as the main outcome measures; Kansu et al 
also documented the absence of symptoms as well as episodes of dacryocystitis and 
obstruction of the neo-ostium 13,14,15.  
 
Ji et al demonstrated a statistically significant benefit in the mucosal flap group with a 98% 
success rate in group A compared to 84% in group B (p<0.05) 11. The other 2 papers 
comparing nasal mucosal flaps showed an increased success in the nasal flap groups but this 
was not statistically significant 13,14. Yuen et al illustrated a statistically significant benefit 
when comparing a lacrimal sac flap to lacrimal flap excision with success of 89.1% in the 
lacrimal flap group and 71.7% in the resection groups (p<0.05) 15. 
 
Other outcome measures: In the papers comparing nasal mucosal flaps, all demonstrated 
either more granulation tissue or needing more debridements in the groups with no 
mucosal flaps. In the 2 RCTs this was statistically significant 11,12,13. 
 
In the two studies comparing lacrimal flaps, Massegeur et al found an increased synechia 
rate in the no lacrimal flap groups although not statistically significant, and no difference in 
granulation 14. In the Yuen paper they found a granulation tissue rate of 6.5% in the lacrimal 
flap group and 17.0% in the no flap group, but again not significant 15.  
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Complications: In the 2 RCTs there were a total of 3 epistaxis with no difference between 
the groups 11,12. In the comparative study comparing mucosal flaps 5 patients had periorbital 
oedema with 4 developing eyelid ecchymosis and 4 epistaxis but there was no significant 
difference between the groups 13.  
 
In the two studies comparing lacrimal flaps there were 12 cases of eyelid haematoma but no 
difference between the groups 14,15.  
 
An assessment of the evidence and results provided was undertaken at our local Clinical 
Trials Unit – given the limited number of RCTs, a meta-analysis could not be performed.  
 
Discussion 
The variety of surgical methods and generally good success rates of them all indicates a lack 
of consensus regarding best management. The above results demonstrate some conflicting 
evidence but overall there appears to be a trend towards preservation of both the nasal 
mucosal tissue and the medial lacrimal sac. The arguments for mucosal preservation in DCR 
surgery are similar to those of frontal sinus surgery.  
 
Overall completeness and applicability of the evidence; 
The 5 studies reviewed cover slightly differing aspects regarding mucosal preservation. Our 
review aimed to focus on nasal mucosal flaps, which 3 studies did. In performing the 
literature search we identified the 2 studies comparing medial lacrimal sac flaps and have 
included them as it was felt there was clinical relevance with the nasal mucosal papers. 
Given that 2 of the papers are RCTs these understandably hold more weight when drawing 
any conclusions regarding the subject matter. We found the Khalifa et al RCT to be the most 
complete with a good description of patient selection, inclusion and exclusion criteria 12. It 
sufficiently details their randomisation procedure and sample size calculations. Importantly, 
this is the only double blinded study.  
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Trial Limitations; 
Quality of the evidence 
The obvious limitations are of the comparative studies. The data is retrospective, and in 
Kansu et al and Yeun et al different surgeons were performing the two different techniques 
13,15. Massegur et al describe the operations taking place at different periods - group A being 
performed from 1998-2000 and group B from 2000 onwards 14. Both of these issues 
introduce significant variability into the process.  
 
There was variability in the type of mucosal or lacrimal sac flap used, the most commonly 
used being the posteriorly based nasal mucosa and lacrimal flaps (see Table 3).  
 
Other than the difference in surgical procedure, there is a wide variation in terms of the 
other adjuncts used. In the two RCTs there is clear description of the surgical procedure and 
in Ji et al the patients were under general anaesthetic, and they used Merogel dressing on 
the flap with and no silicone stents11. In Khalifa et al surgery was performed under local 
anaesthetic and sedation, using tissue glue to the mucosal and lacrimal edges with a 
gelfoam patch as well as silicone stenting 12.  
 
The variation in surgical techniques and adjuncts such as silicone stents and mitomycin C is 
the main limitation of the evidence. Silicone stents were used in both arms of all of the 
studies except Ji et al where they did not use any 11,12,13,14,15. There was variation regarding 
stent removal in Kansu et al and Yuen et al with no documented protocol for their 
removal13,15. Mitomycin C was only used in one of the comparative studies and appears to 
be used in both arms. The use of silicone stents and mitomycin C in both arms of the Yuen 
et al paper left the main difference between the groups being surgical technique and 
therefore improved the study’s relevance and validity for review15.  
 
Without a meta-analysis of the results, we feel that the Yuen et al paper is still valid when 
answering the question of mucosal preservation in DCR surgery 15. In Kansu et al other nasal 
procedures were performed from septoplasty to FESS, although there was no statistical 
difference between the number of procedures performed in each arm 13.  
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Another difference amongst all the papers was the postoperative treatment regimen. This 
differed from antibiotic and steroid eye-drops to nasal irrigation and steroid nasal sprays, 
along with oral antibiotics and anti-inflammatories with no two papers observing the same 
post-operative regime.  
 
Both RCTs followed their patients up for 12 months with an acceptable dropout rate with no 
significant difference between the 2 groups in either study 11,12. In the comparative studies 
however the follow up ranged from 2 to 78 months in Kansu et al, and a minimum of 3 
months in Yuen et al and 6 months in Massegur et al 13,14,15. This is important as not only 
does this illustrate a variability in practice; but also in Khalifa et al they demonstrated that in 
both groups there was a drop in success rates from the 6 to 12 months. This suggests that a 
longer follow up or at least follow up for 12 months is indicated given the potential for late 
failures 12. 
 
Potential bias in review; 
In all but the Khalifa et al paper there is significant potential for bias. The retrospective 
comparative studies as well as the Ji et al RCT were not blinded and although there is 
mention of randomisation by Ji the details and quality of this are not discussed 11. 
Interpretation of outcome measures should be done so with caution. None of the papers 
appeared to use a visual analogue score or other validated scoring system. Although the 
fluorescein/lacrimal irrigation test is commonly used, the variability of the technique used 
from drop application to length of time observing are varied and subjective and therefore 
open to bias. In our clinical experience we have found that a binary approach does not 
reflect the complexity of the symptoms as the patients are rarely either totally symptomatic 
or symptom free. Therefore in future studies we would advise the use of a validated 
patients assessment with a visual analogue score as well as a quality of life assessment, e.g. 
Glasgow Benefit Inventory or Lac-Q 16,17. 
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Comparison with other reviews; 
There are three reviews published recently that outline DCR in practice and include some 
mention of mucosal flaps 18,19,20. They talk of the different techniques but only Marcet et al 
details the evidence behind these, however this is a brief summary of Khalifa et al’s findings 
- there were no other papers included in this review 12,17. 
 
 
Implications for clinical practice; Implications for research; 
Endonasal endoscopic DCR is still a work in progress that has been progressively refined 
over the last 20-30 years. It now has similar or better success rates than the external 
technique that had been the gold standard for so long 21. There is significantly more 
evidence surrounding other aspects of the surgical approach such as silicone stents and 
application of mitomycin C.  
 
There are many factors which influence the success of DCR surgery, with an overall high 
success rate despite variation in surgical technique or adjunct used.  The biggest issue with 
current evidence is the lack of control of the other confounding variables. Comparing study 
against each other was also difficult given the heterogeneous approach to the surgical 
technique and adjuncts used as well as the postoperative regimes. The placement of silicone 
tubes is still contentious and still often used by many surgeons although there is growing 
evidence, including two randomised controlled trails and a meta-analysis, showing no 
difference in primary DCR with or without stenting 22,23,24.  A meta-analysis of the 
application of mitomycin C in endoscopic DCR has shown improved success rates (p=0.004) 
but subgroup analysis found that benefit was only statistically significant if silicone stents 
were not used 25. The perceived risks and representative success rates without using 
mitomycin C results in it still not being used commonly. 
 
The overall quality of evidence is low but there does appear to be a general trend towards 
improved outcomes with reduced granulation in the groups where nasal mucosal and 
lacrimal flaps were preserved but this is not clear-cut. Case series have been published 
demonstrating that DCR with or without mucosal flap preservation has similar success rates 
to the other published literature, but these are non-comparative non-randomised studies 
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26,27,28. It is known that minimal mucosal trauma helps to reduce wound contraction and 
therefore minimise scarring 29. It is established in surgical practice that reducing mucosal 
trauma in frontal sinus surgery and minimisation of bone exposure helps reduce stenosis 30. 
Mann et al. proposed that this is also the case in DCR, where careful approximation of nasal 
mucosa and lacrimal flaps allows healing by primary intention and thus reduces granulation 
31. 
 
Further research is clearly necessary to clarify if mucosal preservation has a benefit in DCR 
surgery compared to mucosal sacrifice. The studies need to be significantly powered and a 
standardised surgical technique used. Also limitations to the number of variables that can 
affect the clinical outcome such as patient selection, the use of stents, mitomycin C and the 
method of performing osteotomies should be accounted for. There needs to be an 
adequate follow up period of at least a year due to late failures and changes to the 
rhinostomy site. Clear outcome measures both subjective and objective with Patient 
Related Outcome Measures (PROMs) should also be assessed in further studies. Given the 
limitations of current evidence we would recommend that until further good quality 
research is available we should be performing a mucosal-sparing technique when 
performing DCR routinely. 
 
No conflict of interest. 
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Table 1. 
 
Type of Study Paper 
Numbers in 
the study 
Surgical 
intervention Blinded Follow up  Outcome measures Success Complications 
RCT 
Ji et al 
2012 
54 group A 
57 group B 
Group A mucosal 
flap 
Group B no flap No 
1,3,6,12 
(months) 
Lacrimal irrigation, 
absence of epiphora and 
discharge 
98% group A, 84% group B 
p<0.05, significantly more 
granulations and scar tissue 
in group B 1 epistaxis  
RCT 
Khalifa 
et al 
2012 
38 group A 
39 group B 
Group A mucosal 
flap 
Group B no flap 
Yes 
double 
blind 
Weekly for 1 
month, 
every 2 
weeks for 3 
months then 
monthly 
Lacrimal irrigation, 
absence of epiphora and 
discharge 
92.1% group A, 87.2% group 
B. No difference. Only 
difference was regarding the 
number of debridement’s 
needed. Significantly more 
for group B.  
Pain under Local 
anaesthetic 45%, no 
difference in epistaxis and 
synechia 
Comparative 
(retrospective) 
Kansu 
et al 
2008 
25 group A 
39 group B 
Group A mucosal 
flap 
Group B no flap No 
1 week, 
1,3,6,12,24 
months 
Lacrimal irrigation, 
absence of epiphora, 
episode of dacryocystitis, 
obstruction of neo ostium  
Group A 100%, group B 
88.3% p 0.08 
Epistaxis, orbital oedema, 
ecchymosis, synechia, 
granulation, re-
obstruction. No difference 
in groups 
 
 
 
Table 2. 
 
Type of Study Paper 
Numbers in 
the study Surgical intervention Blinded 
Follow 
up   Outcome measures Success Complications 
Comparative 
(retrospective) 
Massegur 
2003 
96 group A 
40 group B 
Group A no lacrimal flap 
Group B lacrimal flap No 
1,2,3,4,5,
6 months 
Nasal permeability 
fluorescein 
Group A 92.7% group B 
87.5% not statistically 
significant 
Group A, 5 eyelid 
haematoma, 10 synechia, 
group B 7 eyelid 
haematoma, 3 synechia 
Comparative 
(retrospective) 
Yuen et al 
2004 
46 group A 
53 group B 
Group A lacrimal sac flap, 
Group B no lacrimal flap No 
Differs 
greatly 
Fluorescein at 3 
months   
89.1% in group A, 71.7% 
in group B, p<0.05 
Granulation tissue 6.5% in 
group A, 17.0% group B, 
didn’t comment if 
significant. One damage to 
lacrimal punctum.  
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Paper Group A surgical technique Group B surgical technique 
Ji et al 2012 Posteriorly based nasal mucosa flap cut 
into V shape 
Nasal mucosa removed 
Khalifa et al 2012 Posteriorly based nasal mucosal and 
lacrimal lac flaps 
Nasal mucosa and medial lacrimal sac removed 
Kansu et al 2008 Posteriorly based nasal mucosal and 
lacrimal lac flaps 
Nasal mucosa and medial lacrimal sac removed 
Yuen et al 2004  Nasal mucosa removed, large 
posteriorly based lacrimal flap  
Nasal mucosa and medial lacrimal sac removed 
Massegur 2003 Inferior nasal mucosal flap Inferior and posterior based nasal mucosal flap 
with posterior lacrimal sac flap  
 
Table 3. Table showing the variation in nasal mucosal and lacrimal flaps used in each paper reviewed.  
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